Results 111 to 120 of about 3,726 (180)

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis. [PDF]

open access: yesRheumatology (Oxford)
Marzo-Ortega H   +8 more
europepmc   +1 more source

The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE Study. [PDF]

open access: yesDermatol Ther (Heidelb)
Alexis A   +16 more
europepmc   +1 more source

Real-World Comparison of On-Label Treatment Persistence Through 24 Months Between Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Interleukin-17A Inhibitors. [PDF]

open access: yesAdv Ther
Mease PJ   +13 more
europepmc   +1 more source

Comparative risk of psoriatic arthritis in psoriasis patients on immunomodulators. [PDF]

open access: yesProc (Bayl Univ Med Cent)
Schmidt M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy